Literature DB >> 29235846

Cu(II)-Doped Polydopamine-Coated Gold Nanorods for Tumor Theranostics.

Shuwei Liu1, Lu Wang, Min Lin2, Dandan Wang, Ziqi Song, Shuyao Li1, Rui Ge1, Xue Zhang1, Yi Liu1, Zhimin Li, Hongchen Sun1, Bai Yang1, Hao Zhang1.   

Abstract

Gold nanorods (AuNRs) are potentially useful in tumor theranostics, but the poor stability, high toxicity, and rapid removal by the immune system seriously limit their theranostic applications. In our study, we demonstrate the fabrication of Cu(II)-doped polydopamine-coated AuNR (AuNR@CuPDA), which significantly improves the potentials in tumor theranostics. Besides the improvement of physiological stability and biocompatibility, the PDA shell increases the photothermal performance and prolongs the blood circulation time of AuNRs. The half-life of AuNRs during blood circulation increases from 0.7 to 4.5 h after PDA coating, and the injected dose per gram of tumor tissue is 4.6% ID g-1 for AuNR@CuPDA. In addition to computer tomography imaging, the loading of Cu(II) in PDA shell endows AuNR@CuPDA with magnetic resonance imaging function. Cu(II) doped in PDA shell also exhibits chemotherapeutic behavior, and the tumor inhibitor rate is 31.2%. Further combining 808 nm laser-driven photothermal therapy, tumors were completely ablated, and no recurrence was observed. Liver and renal functions tests and histological analysis of major organs confirm that AuNR@CuPDA is in good safety.

Entities:  

Keywords:  computer tomography imaging; gold nanorods; magnetic resonance imaging; polydopamine; thermo-chemotherapy; tumor theranostics

Mesh:

Substances:

Year:  2017        PMID: 29235846     DOI: 10.1021/acsami.7b13643

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  9 in total

1.  Erratum: Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum.

Authors:  Shuyao Li; Shuwei Liu; Lu Wang; Min Lin; Rui Ge; Xing Li; Xue Zhang; Yi Liu; Lening Zhang; Hongchen Sun; Hao Zhang; Bai Yang
Journal:  Nanotheranostics       Date:  2022-02-18

2.  Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer.

Authors:  You-Hong You; Yu-Feng Lin; Bhanu Nirosha; Huan-Tsung Chang; Yu-Fen Huang
Journal:  Nanotheranostics       Date:  2019-06-06

Review 3.  Polyphenol-Based Particles for Theranostics.

Authors:  Qiong Dai; Huimin Geng; Qun Yu; Jingcheng Hao; Jiwei Cui
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

Review 4.  Nanoparticles modified by polydopamine: Working as "drug" carriers.

Authors:  Anting Jin; Yitong Wang; Kaili Lin; Lingyong Jiang
Journal:  Bioact Mater       Date:  2020-04-18

Review 5.  From Bioinspired Glue to Medicine: Polydopamine as a Biomedical Material.

Authors:  Daniel Hauser; Dedy Septiadi; Joel Turner; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Materials (Basel)       Date:  2020-04-07       Impact factor: 3.623

Review 6.  Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research-A Review.

Authors:  Iasmina Marcovici; Dorina Coricovac; Iulia Pinzaru; Ioana Gabriela Macasoi; Roxana Popescu; Raul Chioibas; Istvan Zupko; Cristina Adriana Dehelean
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

7.  Seedless preparation of Au nanorods by hydroquinone assistant and red blood cell membrane camouflage.

Authors:  Jing Li; Wenjing Wang; Xue Zhang; Hua Yao; Zhenhong Wei; Xiuying Li; Xupeng Mu; Jinlan Jiang; Hao Zhang
Journal:  RSC Adv       Date:  2018-06-11       Impact factor: 3.361

8.  Doxorubicin-loaded Cu2S/Tween-20 nanocomposites for light-triggered tumor photothermal therapy and chemotherapy.

Authors:  Shuwei Liu; Lu Wang; Bin Zhao; Ze Wang; Yinyu Wang; Bin Sun; Yi Liu
Journal:  RSC Adv       Date:  2020-07-10       Impact factor: 4.036

Review 9.  Chemodynamic nanomaterials for cancer theranostics.

Authors:  Jingqi Xin; Caiting Deng; Omer Aras; Mengjiao Zhou; Chunsheng Wu; Feifei An
Journal:  J Nanobiotechnology       Date:  2021-06-28       Impact factor: 10.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.